Precise Uzind Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 08-07-2024
- Paid Up Capital ₹ 0.10 M
as on 08-07-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
About Precise Uzind Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurav Gupta, Shilpa Phadnis, and Pranay Shah serve as directors at the Company.
- CIN/LLPIN
U24239PN2020PTC190852
- Company No.
190852
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2020
- Date of AGM
08 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Precise Uzind Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Gupta  | Director | 16-Jun-2021 | Current |
| Shilpa Phadnis | Director | 19-May-2020 | Current |
| Pranay Shah | Director | 16-Jun-2021 | Current |
Financial Performance of Precise Uzind Pharmaceuticals.
Enhance accessibility to Precise Uzind Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Precise Uzind Pharmaceuticals?
Unlock access to Precise Uzind Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Uzind Healthcare Private LimitedActive 5 years 4 monthsGaurav Gupta and Shilpa Phadnis are mutual person
- Kolhapur Construction Corporation Private LimitedActive 10 years 10 months
Shilpa Phadnis is a mutual person
- Midastouch Market Research Analysts Private LimitedActive 3 years 7 months
Shilpa Phadnis is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Precise Uzind Pharmaceuticals?
Precise Uzind Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Precise Uzind Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Precise Uzind Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
